Researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy. Now they have evidence that the earlier pre-schoolers start this treatment, the better. This real-world study focused on infants younger than 12 months old and reveals that not only is oral immunotherapy effective against peanut allergies, it’s even safer for this age group than it is for toddlers and older pre-schoolers.
Lesen Sie weiter auf: Peanut allergy treatment safest when started for infants under 12 months, researchers find
Quelle: ScienceDaily | Allergy
Titelbild/Grafik by ScienceDaily News
Kommentare und FragenMöchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Mugwort allergy: Study creates basis for vaccine
- Peanut allergy treatment safest when started for infants under 12 months, researchers find
- Dietary fiber in the gut may help with skin allergies
- Targeted micronutrition ameliorates allergy symptoms
- Food allergy is associated with lower risk of SARS-CoV-2 infection
- Longer duration of exclusive breastfeeding has protective effect on childhood asthma
- Researchers discover immune system changes that support peanut allergy remission in children
- Caesarean births not linked to increased risk of food allergy during infancy
- Can a messenger substance considered to be inflammatory alleviate asthma symptoms?
- Researchers studying ways to ease asthma symptoms caused by seasonal allergies